Washington, D.C. 20549


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*

(Last) (First) (Middle)


(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Principal Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/02/2021 M 5,085(1) A $95.42 15,231 D
Common Stock 06/02/2021 F 2,656(2) D $95.42 12,575 D
Common Stock 06/03/2021 S 2,429(1) D $93.88 10,146 D
Common Stock 7,367(3) I 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Right $29.5 06/02/2021 M(1) 5,085 12/02/2012(4) 01/02/2022(4) Common Stock 5,085 $0 0 D
Explanation of Responses:
1. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2021.
2. Payment of exercise price and tax liability by withholding securities incident to the exercise of Stock Appreciation Rights referenced in footnote 4 below.
3. Based on Employee Savings Plan information as of May 31, 2021, the latest date for which such information is reasonably available.
4. Stock Appreciation Right granted pursuant to Ashland's incentive plan which vests in three annual installments: 50% after the first year, the next 25% the second year and the remaining 25% the third year.
/s/ Babatunde Awodiran, Attorney-in-Fact 06/04/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

The undersigned hereby appoints Babatunde Awodiran, signing singly, his or
her true and lawful attorney-in-fact to:

(1) apply for and obtain on behalf of the undersigned the necessary access
codes to file Forms 3, 4, 5 and 144, pursuant to Section 16(a) of the Securities
Exchange Act of 1934 and Rule 144 of the Securities Act of 1933, respectively,
electronically via the EDGAR system pursuant to Regulation S-T and the rules
thereunder, and

(2) act in a filing agent capacity to perform any and all acts for and on behalf
of the undersigned which may be necessary to complete the filing of any such
Form 3, 4, 5 and 144 with the U.S. Securities and Exchange Commission and
any other authority in accordance with Section 16(a) of the Securitie
Exchange Act of 193

The undersigned hereby grants to the attorney-in-fact the full power and
authority, for me and on my behalf, to perform all acts necessary and proper
to be done in the exercise of the rights and powers hereby granted.

The undersigned acknowledges that the foregoing individual is acting under
this Power of Attorney at the request of the undersigned, and is not assuming
any of the undersigned?s responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934 or Rule 144 of the Securities Act of 1933.

The attorney-in-fact shall be authorized to act under this Power of Attorney
only so long as such attorney-in-fact is an officer of Ashland Global Holdings
Inc., or until such time as this Power of Attorney has been revoked, annulled
or set aside.

This Power of Attorney supersedes any and all powers of attorney previously
granted to the attorney-in-fact with regard to the aforementioned; provided,
however, that any action or actions taken prior hereto pursuant to such
superseded powers shall not be deemed to be unauthorized by virtue of this

IN WITNESS WHEREOF, the undersigned has executed this Power of
Attorney as of this 11th day of May, 2021.

/s/ Eric N. Boni